How to buy Cyteir Therapeutics stock
Learn how to easily invest in Cyteir Therapeutics stock.
Cyteir Therapeutics is a biotechnology business based in the US. Cyteir Therapeutics shares (CYT) are listed on the NASDAQ and all prices are listed in US Dollars. Cyteir Therapeutics employs 46 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Cyteir Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – CYT. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Cyteir Therapeutics stock price (NASDAQ: CYT)Use our graph to track the performance of CYT stocks over time.
Cyteir Therapeutics shares at a glance
|Latest market close||$2.80|
|52-week range||$1.13 - $2.81|
|50-day moving average||$2.65|
|200-day moving average||$1.98|
|Wall St. target price||$2.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.16|
Buy Cyteir Therapeutics stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Cyteir Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Cyteir Therapeutics price performance over time
|1 week (2023-09-15)||2.8|
|1 month (2023-08-23)||2.56%|
|3 months (2023-06-23)||47.37%|
|6 months (2023-03-23)||56.42%|
|1 year (2022-09-23)||40.70%|
|2 years (2021-09-23)||-82.09%|
|3 years (2020-09-19)||N/A|
|5 years (2018-09-19)||N/A|
Cyteir Therapeutics financials
|Gross profit TTM||$-16,591,000|
|Return on assets TTM||-16.33%|
|Return on equity TTM||-27.94%|
|Market Capitalization||$99.4 million|
TTM: trailing 12 months
Cyteir Therapeutics share dividends
We're not expecting Cyteir Therapeutics to pay a dividend over the next 12 months.
Have Cyteir Therapeutics's shares ever split?
Cyteir Therapeutics's shares were split on a 2:1 basis on 17 September 2014. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cyteir Therapeutics shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cyteir Therapeutics shares which in turn could have impacted Cyteir Therapeutics's share price.
Cyteir Therapeutics share price volatility
Over the last 12 months, Cyteir Therapeutics's shares have ranged in value from as little as $1.13 up to $2.81. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cyteir Therapeutics's is 0.0991. This would suggest that Cyteir Therapeutics's shares are less volatile than average (for this exchange).
To put Cyteir Therapeutics's beta into context you can compare it against those of similar companies.
- Sonnet Biotherapeutics (SONN.US): 0.3984
- PDS Biotechnology (PDSB.US): 1.6258
- Vertex Pharmaceuticals (VRTX.US): 0.5059
Cyteir Therapeutics overview
Cyteir Therapeutics, Inc. , a clinical-stage biotechnology company, develops and commercializes the oncology therapeutics. Its lead product CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. Cyteir Therapeutics, Inc. was incorporated in 2012 and is headquartered in Lexington, Massachusetts. .
Frequently asked questionsWhat percentage of Cyteir Therapeutics is owned by insiders or institutions?
Currently 11.767% of Cyteir Therapeutics shares are held by insiders and 66.784% by institutions. How many people work for Cyteir Therapeutics?
Latest data suggests 46 work at Cyteir Therapeutics. When does the fiscal year end for Cyteir Therapeutics?
Cyteir Therapeutics's fiscal year ends in December. Where is Cyteir Therapeutics based?
Cyteir Therapeutics's address is: 128 Spring Street, Lexington, MA, United States, 02421 What is Cyteir Therapeutics's ISIN number?
Cyteir Therapeutics's international securities identification number is: US23284P1030
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert